Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Salbutamol in TTN
NCT07350421Not yet recruiting
- Sponsor
- Tishreen University
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of salbutamol in transient tachypnea of the newborn (TTN) (2 arms), sponsored by Tishreen University. Primary endpoint: Improvement in respiratory distress signs according to the modified Downes score at 72 hours. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
salbutamol
03
Conditions
transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on NCT07350421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07350421.